Umbra Applied Technologies Group Inc (UATG)

[RJ999]

**PR** UAT Group Announces Subsidiary Company UAT, Partners with Medical Company

http://www.marketwatch.com/story/uat-group-announces-subsidiary-company-uat-partners-with-medical-company-2017-10-17-916016?siteid=nbsh

TAMPA, FL, Oct 17, 2017 (Marketwired via COMTEX) -- TAMPA, FL--(Marketwired - Oct 17, 2017) - Umbra Applied Technologies Group UATG, -17.14% announced today that it has formed a strategic partnership with Next Cast & Brace Corporation to supply the high-tech cast maker with UAT's Hygieia ASP (Active Silver Protection) antimicrobial technology. Next Cast manufactures what is inarguably the worlds most advanced orthopedic cast and brace systems currently available. The revolutionary new cast is scheduled to be released early 2018 and will feature an antimicrobial silicone surface, powered by UAT's Hygieia ASP technology, where the cast comes in contact with the patient's skin.

Chief Executive Officer, Alex Umbra stated, "This is the joining of two highly innovative companies with a very clear vision of how technology can improve lives and change the world. You could not ask for a more perfect partnership. This new strategic partnership is indicative of the synergy that we at UAT see as a broader opportunity between UAT and the entire medical landscape. Hygieia technology is paradigm shifting and will advance medical care and treatment exponentially. UAT is at the forefront of antimicrobial efficacy and it is Hygieia that will carry the medical industry into the future in this area of treatment and infection prevention."

The strategic partnership between Umbra Applied technologies and Next Cast is in keeping with UAT's renewed focus on growth and revenues after evolving from a primarily R&D company. The scalability of the Hygieia ASP technology appears to be limitless as UAT heads into the end of the year with an eye on improved revenues in the coming year.

Umbra added, "This partnership reveals, to a limited extent, what we have been working towards for more than a year and signals the beginning execution of a more robust UAT branding effort. Hygieia will be the product that introduces UAT to businesses as well as our homes."

The company has indicated that other products are on the horizon with much speculation surrounding the release of its new surgical cleanser and it being made available as an antibacterial foaming hand wash for the home. The not yet named surgical cleanser is slated for release next year and is for hospital and medical use only. With the introduction of an advanced antimicrobial hand soap for home use, UAT could indeed become a household name.

Next Cast commented that, "The company is very excited about our new partnership with UAT. UAT has proven to be an industry leader in breakthrough technology and a valued partner in working with our engineers to bring additional innovation to the most dynamic and advanced cast in the world."

Chief Financial Officer, Thomas L. Crom commented, "This partnership will help to further increase the competitive edge Next Cast & Brace has over its competitors while simultaneously increasing UAT's footprint within the medical industry. In addition, this new contract further delivers on a promise we made to the shareholders to be revenue positive within 5 years from the day we opened the doors." Beginning in January of 2018, UAT will begin delivering Hygieia ASP technology to NextCast for the manufacturing of 100,000 units in the first year of a three-year contract for a total of up to half a million units through 2021.